Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | DRD3 | P35462 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25281145 | 0.83 | PNMT (0.46) | PNMTCYP11B2DRD2DRD3 | |
| SCHEMBL30183105 | 0.83 | PNMT (0.46) | PNMTCYP11B2DRD2DRD3 | |
| Hydrochloric Acid SCHEMBL31186539 | 0.82 | PNMT (0.45) | PNMTCYP11B2DRD2DRD3 | |
| Hydrochloric Acid SCHEMBL25281366 | 0.82 | PNMT (0.45) | PNMTCYP11B2DRD2DRD3 | |
| SCHEMBL16180568 | 0.74 | CYP11B2 (0.33) | PNMTCYP11B2DRD2DRD3 | |
| Trifluoroacetic Acid SCHEMBL31186449 | 0.71 | KDM1A (0.41) | PNMTDRD2DRD3 | |
| SCHEMBL22923562 | 0.71 | DRD2 (0.33) | DRD2 | |
| SCHEMBL31489022 | 0.71 | DRD2 (0.33) | DRD2 | |
| SCHEMBL11582237 | 0.71 | — | — | |
| SCHEMBL20565032 | 0.71 | RIPK1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120476110-B | Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof | SHANGHAI HANSOH BIOMEDICAL Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-119264042-A | Cyclopentane derivative-containing inhibitor, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2025-01-07 | — | — | CN | disclosed |